Clinical Trials Directory

Trials / Unknown

UnknownNCT04413565

Infection Rate of One-Stage Bilateral TKR - One Surgeon Sequential vs. Two Surgeon Simultaneous: A Randomized Controlled Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
413 (estimated)
Sponsor
Bezmialem Vakif University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The use of bilateral total knee replacements (TKR) is increasing with the number of patients with bilateral end-stage knee osteoarthritis. Bilateral TKR can be performed in three different ways: single-stage, two-team simultaneous bilateral TKR (two surgeons bilateral TKR); single-stage, a sequential bilateral TKR (single surgeon bilateral TKR); and two-stage bilateral TKR. Periprosthetic joint (PJI) infections are serious complications after TKR that negatively affect the aimed outcome, decrease patient satisfaction, and increase morbidity and mortality. The incidence of PJI is 1-2% and the number of cases is projected to grow as the indications for TKR continue to increase. Investigators will prospectively compare the incidence of periprosthetic joint infection between groups.

Detailed description

924 knees (462 participants) will prospectively be randomized into 2 groups: two surgeons bilateral TKA and single surgeon bilateral TKA. While 2 surgeons will perform simultaneous total knee arthroplasty in the two surgeons' bilateral TKA group, one surgeon will perform sequentially in the single surgeon bilateral TKA group. The primary outcome is to compare the incidence of PJI between the groups. Secondary, logistic regression use to estimate the effect of two surgeons bilateral TKA and single surgeon bilateral TKA on the likelihood of a patient being infected.

Conditions

Interventions

TypeNameDescription
PROCEDURESimultaneous bilateral total knee arthroplastyTwo surgeon bilateral TKA group
PROCEDURESequenced bilateral TKASingle surgeon bilateral TKA group

Timeline

Start date
2016-12-08
Primary completion
2020-11-30
Completion
2020-12-31
First posted
2020-06-04
Last updated
2020-06-04

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04413565. Inclusion in this directory is not an endorsement.